中华普通外科杂志
中華普通外科雜誌
중화보통외과잡지
CHINESE JOURNAL OF GENERAL SURGERY
2014年
12期
937-940
,共4页
牛海刚%高君%丁雪梅%柯山%孙文兵%辛宗海%宁纯民%国世刚%李晓龙
牛海剛%高君%丁雪梅%柯山%孫文兵%辛宗海%寧純民%國世剛%李曉龍
우해강%고군%정설매%가산%손문병%신종해%저순민%국세강%리효룡
血管瘤%手术后并发症%射频消融
血管瘤%手術後併髮癥%射頻消融
혈관류%수술후병발증%사빈소융
Hemangioma%Postoperative complications%Radiofrequency ablation
目的 比较CT和腹腔镜路径射频消融(radiofrequency ablation,RFA)治疗横膈下方肝血管瘤的安全性和有效性.方法 回顾性分析RFA治疗43例患者的43个膈下肝血管瘤的临床资料,19例接受CT引导下经皮RFA治疗(CT组),24例接受腹腔镜路径RFA治疗(腹腔镜组).结果 43例肝血管瘤的直径为6.0~11.8cm,平均(9.4±1.7 cm).2组患者血管瘤直径差异无统计学意义(t=0.42,P>0.05).所有患者均顺利完成RFA治疗,无技术失败.两组消融时间差异无统计学意义(t=0.07,P>0.05).CT组和腹腔镜组完全消融率分别为94.7%(18/19)和91.7%(22/24)(Fisher,P>0.05).RFA治疗后,15例患者发生21例次胸部并发症,其中CT组13例患者(68.4%,13/19),腹腔镜组2例患者(8.3%,2/24)(Fisher,P<0.05).2例出现严重并发症(胸腔积液和膈肌破裂,Ⅲ级),均发生在CT组,其余为轻微并发症(Ⅰ级).所有轻微并发症经保守治疗痊愈,2例严重并发症分别通过胸腔引流和胸腔镜手术治愈.结论 腹腔镜路径下RFA治疗膈下肝血管瘤可明显降低胸部并发症发生率,是膈下肝血管瘤首选的治疗方案.
目的 比較CT和腹腔鏡路徑射頻消融(radiofrequency ablation,RFA)治療橫膈下方肝血管瘤的安全性和有效性.方法 迴顧性分析RFA治療43例患者的43箇膈下肝血管瘤的臨床資料,19例接受CT引導下經皮RFA治療(CT組),24例接受腹腔鏡路徑RFA治療(腹腔鏡組).結果 43例肝血管瘤的直徑為6.0~11.8cm,平均(9.4±1.7 cm).2組患者血管瘤直徑差異無統計學意義(t=0.42,P>0.05).所有患者均順利完成RFA治療,無技術失敗.兩組消融時間差異無統計學意義(t=0.07,P>0.05).CT組和腹腔鏡組完全消融率分彆為94.7%(18/19)和91.7%(22/24)(Fisher,P>0.05).RFA治療後,15例患者髮生21例次胸部併髮癥,其中CT組13例患者(68.4%,13/19),腹腔鏡組2例患者(8.3%,2/24)(Fisher,P<0.05).2例齣現嚴重併髮癥(胸腔積液和膈肌破裂,Ⅲ級),均髮生在CT組,其餘為輕微併髮癥(Ⅰ級).所有輕微併髮癥經保守治療痊愈,2例嚴重併髮癥分彆通過胸腔引流和胸腔鏡手術治愈.結論 腹腔鏡路徑下RFA治療膈下肝血管瘤可明顯降低胸部併髮癥髮生率,是膈下肝血管瘤首選的治療方案.
목적 비교CT화복강경로경사빈소융(radiofrequency ablation,RFA)치료횡격하방간혈관류적안전성화유효성.방법 회고성분석RFA치료43례환자적43개격하간혈관류적림상자료,19례접수CT인도하경피RFA치료(CT조),24례접수복강경로경RFA치료(복강경조).결과 43례간혈관류적직경위6.0~11.8cm,평균(9.4±1.7 cm).2조환자혈관류직경차이무통계학의의(t=0.42,P>0.05).소유환자균순리완성RFA치료,무기술실패.량조소융시간차이무통계학의의(t=0.07,P>0.05).CT조화복강경조완전소융솔분별위94.7%(18/19)화91.7%(22/24)(Fisher,P>0.05).RFA치료후,15례환자발생21례차흉부병발증,기중CT조13례환자(68.4%,13/19),복강경조2례환자(8.3%,2/24)(Fisher,P<0.05).2례출현엄중병발증(흉강적액화격기파렬,Ⅲ급),균발생재CT조,기여위경미병발증(Ⅰ급).소유경미병발증경보수치료전유,2례엄중병발증분별통과흉강인류화흉강경수술치유.결론 복강경로경하RFA치료격하간혈관류가명현강저흉부병발증발생솔,시격하간혈관류수선적치료방안.
Objective To compare the safety and therapeutic efficacy of computed tomography (CT) guided versus laparoscopic RF ablation for hepatic hemangiomas abutting the diaphragm.Methods 43 cases of hepatic hemangiomas abutting the diaphragm were divided into two groups receiving respectively CT guided (19 cases) or laparoscopic RF ablation (laparoscopic ablation group,24 cases).Results The mean diameter of the 43 hemangiomas was (9.4 ± 1.7) cm (6.0-11.8 cm).There was no difference in the diameter of hemangiomas between the two groups (t =0.42,P > 0.05).RF ablation was performed successfully for all patients.There was no difference in ablation times between groups (t =0.07,P >0.05).There were 21 thoracic complications in 15 patients,including 13 (68.4%,13/19) patients in the CT-guided ablation group and 2 (8.3%,2/24) patients in the laparoscopic ablation group (Fisher,P < 0.05).According to the Dindo-Clavienclassification,2 complications (pleural effusion and diaphragmatic rupture,Grade Ⅲ) were severe and the remaining were minor (Grade Ⅰ).All the 2 major complications were in the CT-guided ablation group.All the minor complications were treated successfully with conservative measures,and the 2 major complications received chest tube drainage and thoracoscopic surgery respectively.Complete ablation was achieved in 94.7 % (18/19) and 91.7% (22/24) in the CT-guided ablation group and the laparoscopic ablation group,respectively (Fisher,P > 0.05).Conclusions Laparoscopic RF ablation therapy should be used for the first line treatment option for hepatic hemagioma abutting the diaphragm,which can avoid thermal injury to the diaphragm effectively and reduce the thoracic complications.